Boehringer Ingelheim allocates 1 m euro COVID relief fund in India

Boehringer Ingelheim allocates 1 m euro COVID relief fund in India

Germany-based biopharmaceutical company Boehringer Ingelheim is making available a euro one million COVID relief fund to enable sustenance and livelihoods of underserved and tribal communities, and address the medical needs of patients in India, through the 2021-22 financial year.

The company through its global support program aims to address the current needs of vulnerable communities, balancing it with initiatives that secure their future. Since January 2020, the organization has been engaged in financial and medical relief for COVID care, sustaining the lives of people impacted by the pandemic conditions.

The relief package includes support to underserved and tribal communities in Coimbatore, Tamil Nadu, under ‘Making More Health’, Boehringer Ingelheim’s long-term social initiative. This program works on the holistic development of village communities, enabling people to live healthier and more empowered lives. A special focus on children’s development ensures the sustained well-being and future of the communities.

The relief package also supports current medical needs to ensure the livelihoods of people in migrant and tribal communities in Maharashtra, to sustain and help them manage the unprecedented times, said Vani Manja, Managing Director, Boehringer Ingelheim India.

“During these trying times, all of us at Boehringer Ingelheim are part of the collective effort in fighting COVID-19. Through our Global Support Program, we want to contribute with relevant means to the current situation and support especially those who need immediate assistance,” says Médard Schoenmaeckers, Global Head Communications & Public Affairs at Boehringer Ingelheim, overseeing the Global Support Program.